Connecta Therapeutics
Connecta Therapeutics is a biotechnology company that develops new treatments for unresolved medical needs of the central nervous system.
Connecta Therapeutics operates in biotechnology, health care, medical, neuroscience based in European Union (EU), Europe, Middle East, and Africa (EMEA), founded in 2019.
Its activity falls under biotechnology, health care, medical, neuroscience; the profile below is assembled from public directory data.
Its base of operations is European Union (EU), Europe, Middle East, and Africa (EMEA).
The company is listed at the Seed stage of development.
The company reports a headcount in the c_00001_00010 range.
Public records show total funding of about $4.4M.
| Sector | Biotechnology, Health Care, Medical, Neuroscience |
|---|---|
| Headquarters | European Union (EU), Europe, Middle East, and Africa (EMEA) |
| Founded | 2019 |
| Employees | c_00001_00010 |
| Stage | seed |
| Total funding | $4,400,000 |
Website: connectatherapeutics.com
Browse related
Full contact details are available to registered Pixilab members.
Create a free account
Create a free account